[Federal Register Volume 65, Number 19 (Friday, January 28, 2000)]
[Notices]
[Pages 4563-4564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-1936]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the pubic as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the

[[Page 4564]]

provisions set forth in sections 552b(c)(6) and 552b(c)(9), Title 5 
U.S.C., as amended. The discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the review 
of applications, and information concerning NCI and/or its contractors, 
the disclosure of which would constitute a clearly unwarranted invasion 
of personal privacy, and the premature disclosure of discussions 
related to personnel and programmatic issues would be likely to 
significantly frustrate the subsequent implementation of 
recommendations.

    Name of Committee: National Cancer Advisory Board.
    Dates: February 15-16, 2000.
    Open: February 15, 9:00 a.m. to 3:45 p.m., February, 16, 9:00 
a.m. to 12:00 p.m.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups, http://deainfo.nci.nih.gov/ADVISORY/boards, htm Tentative 
Agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Closed: February 15, 2000, 4 p.m. to Recess.
    Agenda: Review of Grant Applications.
    Place: Building 31, C, Wing, 6 Floor, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Contact Person: Marvin R. Kalt, Executive Secretary, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard, 8th Floor, Room 8022, Bethesda, MD 20892-8327, (301) 496-
5147.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Cancer Centers.
    Open: February 15, 12 p.m. to 1 p.m.
    Agenda: Annual Guideline Update.
    Place: Building 31, C Wing, 6 Floor, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Contact Person: Brian Kimes, Executive Secretary, Office of 
Centers, Training, and Resources, National Cancer Institute, 
National Institutes of Health, Executive Plaza North--Suite 502, 
6130 Executive Boulevard, Bethesda, MD 20892-8327, (301) 496-8537.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; or 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 83.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 19, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-1936 Filed 1-27-00 8:45am]
 BILLING CODE 7555-01-M